Ogranichennyy tumorogennyy potentsial CD34+CD38+ transformirovannykh kletok pri ostrom mieloblastnom leykoze yavlyaetsya artefaktom

References

[1] 1. Bhatia М., Wang J.С, Kapp U., Bonnet D., Dick J.Е. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. PNAS 1997; 94: 532D-5.

[2] Krause D., Van Etten R. Right on target: eradicating leukemic stem cells. TRENDS in Molecular Medicine 20D7; 13(11]: 470-81.

[3] Lapidot Т., Sirard C, Vormoor J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367(6464]: 645-8.

[4] Shultz L, Schweitzer P., Christiansen S. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 1995; 154: 180-91.

[5] Tanaka Т., Kitamura F., Nagasaka Y. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J. Exp. Med. 1993; 178: 1103-7.

[6] Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997; 3: 730-7.

[7] Taussig D.C., Pearce D.J., Simpson С et al. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 2005; 106: 4086-92.

RIGHTS & PERMISSIONS

Eco-Vector